RankingsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Repurchases of common stock

ABBOTT LABORATORIESABT

Market cap
$223B
P/E ratio
SummaryFinancials
Period EndRepurchases of common stock (Million USD)YoY (%)
Dec 31, 20241,295+5.54%
Dec 31, 20231,227-67.67%
Dec 31, 20223,795+65.07%
Dec 31, 20212,299+470.47%
Dec 31, 2020403-43.87%
Dec 31, 2019718+201.68%
Dec 31, 2018238+103.42%
Dec 31, 2017117-77.59%
Dec 31, 2016522-76.67%
Dec 31, 20152,237+1.91%
Dec 31, 20142,195+36.76%
Dec 31, 20131,605-32.11%
Dec 31, 20122,364+2970.16%
Dec 31, 201177-91.12%
Dec 31, 2010867

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)